Ulcerative Colitis (DBCOND0029012)

Identifiers

Synonyms
Colitis, Ulcerative (UC) / Ulcerative Colitis (UC) / Colitis, Ulcerative / UC / Ulcerative colitis / Colitis ulcerative / Ulcerative colitis, unspecified / Proctocolitis, idiopathic / Idiopathic proctocolitis / Ulcerative colitis (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Betamethasone
A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
Budesonide
A corticosteroid used to treat Crohn's disease, asthma, COPD, hay fever and allergies, and ulcerative colitis.
Bupivacaine
A local anesthetic used in a wide variety of superficial and invasive procedures.
Cortisone acetate
A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones.
Dexamethasone
A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.
Hydrocortisone
A glucocorticoid used to treat corticosteroid-responsive dermatoses, endocrine disorders, immune conditions, and allergic disorders.
Hydrocortisone acetate
A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses and ulcerative colitis.
Hydrocortisone succinate
A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Mercaptopurine
An antineoplastic agent used to treat acute lymphocytic leukemia.
Methylprednisolone
A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Methylprednisolone hemisuccinate
A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Olsalazine
An anti-inflammatory aminosalicylate used in the treatment of inflammatory bowel disease and ulcerative colitis.
Phylloquinone
A fat soluble vitamin used to treat hemorrhagic conditions in infants and coumarin overdoses.
Prednisolone
A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
Prednisone
A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
Sodium metabisulfite
An ingredient used in products to treat dehydration and replace electrolytes.
No drug targets
Tetracosactide
A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03173144
Chronic Inflammatory Disease, Lifestyle and Treatment ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT04089514
A Real-world Study of Imraldi® UseNot AvailableNot Availablecompleted
NCT06663605
Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.No drug interventionstreatment1recruiting
NCT06667934
Clinical Trial of Zuoqing SAN in Treating Ulcerative ColitisNo drug interventionstreatment1 / 2not_yet_recruiting
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisNo drug interventionstreatment1 / 2recruiting
NCT06655415
Family Members at INcreased-risk for Developing Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06657001
Enabling Microbiomics- Driven Personalized NutritionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01971814
Early Serum Infliximab Levels in Severe Ulcerative Colitis.basic_science1completed
NCT05271773
Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05316220
A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitistreatment3not_yet_recruiting
NCT03653026
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT04550130
Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT02738125
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT02217722
Use of the Ulcerative Colitis Diet for Induction of RemissiontreatmentNot Availableterminated
NCT02065622
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitistreatment3completed
NCT01364896
Anal Human Papillomavirus in Inflammatory Bowel Disease StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01277419
German Spondyloarthritis Inception CohortNo drug interventionsNot AvailableNot Availablerecruiting
NCT03695185
A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapytreatment2completed
NCT02087878
A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell LymphomaNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03801928
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel DiseaseNot AvailableNot Availablecompleted
NCT01848561
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03914261
Expanded Access to RisankizumabNot AvailableNot Availableno_longer_available
NCT01877577
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis DNo drug interventionstreatmentNot Availablecompleted
NCT03920254
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Studytreatment2 / 3terminated
NCT02778464
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03758443
Efficacy & Safety of TD-1473 in Ulcerative Colitistreatment2 / 3terminated
NCT03223012
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceNo drug interventionsNot AvailableNot Availablecompleted
NCT03006068
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)treatment3active_not_recruiting
NCT05377580
A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT03398148
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2 / 3completed
NCT02819635
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)treatment2 / 3completed
NCT03456206
Chronic Inflammatory Disease, Lifestyle and Risk of DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02049775
Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)No drug interventionsdiagnosticNot Availableunknown_status
NCT05414578
NORDTREAT Prospective Study on Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04672161
Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) PatientsNo drug interventionspreventionNot Availablecompleted
NCT04254783
A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Diseasetreatment1completed
NCT03609905
Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitistreatment1 / 2unknown_status
NCT04143633
Low FODMAP Diet on Nutritional Status, Disease Activity and Gut Microbiota in IBS and UC With Normal or Overweight BMINo drug interventionstreatmentNot Availableunknown_status
NCT02345733
Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitistreatment4completed
NCT02108821
Fecal Microbiota Transplantation in Pediatric Patientstreatment1completed
NCT05960864
Chinese Spondyloarthritis Inception Cohort (CESPIC)Not AvailableNot Availablenot_yet_recruiting
NCT06604273
Unravelling Intestinal Fibrosis in Ulcerative ColitisNo drug interventionsbasic_science2 / 3recruiting
NCT06604260
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease PatientsNo drug interventionsdiagnostic2recruiting
NCT06606808
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Diseaseother1 / 2not_yet_recruiting
NCT03398135
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitistreatment3active_not_recruiting
NCT06646757
Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome DisabilityNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participantsother3recruiting
NCT03596645
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT05242484
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2active_not_recruiting
NCT05370885
VE202 in Patients with Mild-to-Moderate Ulcerative Colitistreatment2recruiting
NCT05499130
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Diseasetreatment2active_not_recruiting
NCT05528510
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT05588843
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitistreatment2recruiting
NCT05668013
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Diseasetreatment2recruiting
NCT06049017
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT06294925
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative ColitisNot AvailableNot Availablerecruiting
NCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisNot AvailableNot Availablerecruiting
NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)treatment3not_yet_recruiting
NCT06660693
Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitistreatment3not_yet_recruiting
NCT04630028
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)treatment3active_not_recruiting
NCT05659953
LMT503 First-in-human SAD, MAD, and FE StudyNo drug interventionstreatment1not_yet_recruiting
NCT05731128
A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))treatment2recruiting
NCT06260163
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitistreatment3recruiting
NCT04890262
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitistreatment2 / 3recruiting
NCT06575595
Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)treatment1recruiting
NCT02678052
OTIS Vedolizumab Pregnancy Exposure RegistryNot AvailableNot Availablecompleted
NCT04372108
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisNot AvailableNot Availablerecruiting
NCT05092269
A Long-term Extension Study of Ustekinumab in Pediatric Participantsother3recruiting
NCT05369832
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practicetreatment4recruiting
NCT03912714
COlonic Salvage by Therapeutic Appendectomy.No drug interventionstreatmentNot Availablecompleted
NCT06246123
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean ParticipantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04779307
A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC)treatment3active_not_recruiting
NCT05291689
A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults with UCNo drug interventionstreatment2active_not_recruiting
NCT05611671
A Study to Evaluate MORF-057 in Adults with Moderately to Severely Active UCNo drug interventionstreatment2active_not_recruiting
NCT00503243
Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitistreatment3completed
NCT02612103
Biomarkers in Inflammatory Bowel DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT00922103
A Study to Investigate the Ileo Neo Rectal Anastomosis Compared to the Ileo Pouch Anal Anastomosis for Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT02469103
The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative ColitisNo drug interventionsdiagnosticNot Availablecompleted
NCT03100864
This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patientstreatment2completed
NCT03494764
Hyperbaric Oxygen Therapy for Ulcerative Colitis FlaresNo drug interventionstreatment2completed
NCT01604564
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04677179
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)treatment2terminated
NCT04646187
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Diseasetreatment4enrolling_by_invitation
NCT01953354
Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisNo drug interventionstreatment2terminated
NCT00463151
An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitistreatment2completed
NCT04959851
A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)No drug interventionsNot AvailableNot Availablecompleted
NCT03460847
Fecal Microbiota Alterations in Steroid Refractory Active Colitis UlcerosaNo drug interventionsNot AvailableNot Availablecompleted
NCT05796245
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT04597905
Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in EuropeNo drug interventionsNot AvailableNot Availablecompleted
NCT01908283
Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel DiseaseNo drug interventionsprevention4completed
NCT02399683
Immune Modulation From Trichuris TrichiuraNo drug interventionsNot AvailableNot Availablecompleted
NCT06065228
Therapeutic Endpoint in Pediatric IBD ConditionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01863771
A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.treatment3completed
NCT02745678
Localized Therapeutics for the Treatment of Gastrointestinal Disorders IINo drug interventionstreatment1completed
NCT04647578
Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03937609
TITRATE (inducTIon for acuTe ulceRATivE Colitis)treatment4recruiting
NCT00317356
A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitistreatment2terminated
NCT02412085
Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remissiontreatment4unknown_status
NCT02799615
Anti-TNF Therapy for Refractory Colitis in Hospitalized ChildrenNot AvailableNot Availablecompleted
NCT03844932
A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitistreatment2terminated
NCT00676832
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitistreatment2completed
NCT03532932
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT03101800
Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitistreatment3unknown_status
NCT02762500
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative ColitisNo drug interventionstreatment2completed
NCT04873700
A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)No drug interventionsNot AvailableNot Availablecompleted
NCT02770599
Improving the Health Care in Inflammatory Bowel Disease.No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02743806
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Diseasetreatment4terminated
NCT00587236
Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & CholangitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02407236
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisNot Available3completed
NCT03662919
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyNot AvailableNot Availablecompleted
NCT03648541
BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitistreatment2completed
NCT01301417
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression AnastomosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02246686
Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa PatientsNo drug interventionstreatment2terminated
NCT02129439
Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis PatientsNo drug interventionstreatment1 / 2completed
NCT00487539
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitistreatment2 / 3completed
NCT01036022
Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisNo drug interventionstreatment2completed
NCT05156125
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT03151525
Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitistreatment4unknown_status
NCT02611830
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitistreatment3completed
NCT02647866
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitistreatment2completed
NCT02903966
GSK2982772 Study in Subjects With Ulcerative ColitisNo drug interventionstreatment2completed
NCT03893565
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative ColitisNo drug interventionstreatment2terminated
NCT00488774
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitistreatment2 / 3terminated
NCT01959282
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitistreatment2completed
NCT03412682
To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitistreatment3completed
NCT00534131
Anterior Perineal Plane for Ultra Low Anterior Resection of the RectumNo drug interventionstreatmentNot Availablecompleted
NCT04721873
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patientstreatment2recruiting
NCT06025227
Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.Not AvailableNot Availableavailable
NCT04457960
A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative ColitisNo drug interventionstreatment1terminated
NCT01493960
The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patientstreatment3completed
NCT02925260
MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI PouchographyNo drug interventionsNot AvailableNot Availablecompleted
NCT02634060
Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction DestinyNo drug interventionsdiagnosticNot Availablecompleted
NCT03999294
Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT04872491
A Study of Vedolizumab in Adults in Real-World PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT03669029
Optimization of Golimumab Treatment in Ulcerative Colitistreatment4unknown_status
NCT00545389
Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476treatment2completed
NCT00151944
Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.treatment3completed
NCT02801240
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT03011268
Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?No drug interventionstreatmentNot Availableactive_not_recruiting
NCT00984568
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)treatment3terminated
NCT02497469
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitistreatment3completed
NCT02620046
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Diseasetreatment3completed
NCT04112212
Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patientsother1completed
NCT00747110
Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)treatment3completed
NCT00748410
Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitistreatment2terminated
NCT02537210
Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative ColitistreatmentNot Availablecompleted
NCT01294410
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2completed
NCT02825914
CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)No drug interventionstreatmentNot Availablecompleted
NCT01684514
Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentNo drug interventionsdiagnosticNot Availablecompleted
NCT06359808
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02943538
Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)No drug interventionsNot AvailableNot Availablecompleted
NCT05271838
Protein and Magnesium in Ulcerative ColitisNo drug interventionstreatmentNot Availableunknown_status
NCT04259138
Determination of the Optimal Treatment Target in Ulcerative Colitistreatment4active_not_recruiting
NCT03029143
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitistreatment4completed
NCT04074590
Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative ColitisNo drug interventionstreatment2terminated
NCT02840721
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.treatment2completed
NCT00355602
Antibiotics for the Treatment of Ulcerative ColitistreatmentNot Availablecompleted
NCT02569333
Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative ColitisNo drug interventionshealth_services_researchNot Availablecompleted
NCT01331551
Mesalamine and Reproductive Health StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02452151
"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"treatment4unknown_status
NCT02000453
Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.No drug interventionstreatment1terminated
NCT01984047
Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002No drug interventionstreatment1completed
NCT00746447
Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)prevention3completed
NCT03841045
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02910245
Mercaptopurine Therapy in Ulcerative Colitistreatment3unknown_status
NCT04488198
Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel DiseasesNo drug interventionstreatmentNot Availablerecruiting
NCT02463305
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)No drug interventionstreatment0withdrawn
NCT01658605
A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitistreatment2withdrawn
NCT00474097
Follow-Up Phone Calls After Colorectal SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02085083
Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel DiseaseNo drug interventionshealth_services_researchNot Availablecompleted
NCT01988961
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2completed
NCT04567628
Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical OutcomesNo drug interventionsNot AvailableNot Availablecompleted
NCT03444311
Combined Nutritional Therapies for the Treatment of Ulcerative ColitisNo drug interventionstreatmentNot Availableterminated
NCT01099111
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT02629211
Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBDNo drug interventionsdiagnosticNot Availableunknown_status
NCT02316678
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease TherapeuticsNo drug interventionsNot AvailableNot Availablecompleted
NCT03378388
A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real LifeNo drug interventionsNot AvailableNot Availableterminated
NCT04989907
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in SwitzerlandNo drug interventionsNot AvailableNot Availablecompleted
NCT03329209
A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participantsother1completed
NCT04032756
Tofacitinib Registry of Patients With Ulcerative Colitis in GermanyNo drug interventionsNot AvailableNot Availableterminated
NCT05504915
Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center OsijekNo drug interventionsNot AvailableNot Availablecompleted
NCT01240915
A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitistreatment2completed
NCT02165215
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitorstreatment3completed
NCT05382715
A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative ColitisNot AvailableNot Availablerecruiting
NCT02760615
Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Studytreatment4withdrawn
NCT02357537
Decentralized Dietary UC Pilot TrialNo drug interventionshealth_services_researchNot Availableunknown_status
NCT02043600
Randomized-controlled Trial of Yoga for Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT02601300
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitistreatment2completed
NCT02727959
Inflammatory Bowel Disease in South Eastern NorwayNo drug interventionsNot AvailableNot Availablecompleted
NCT05831670
An Early Phase 2 Clinical Study of KSP-0243No drug interventionstreatment2active_not_recruiting
NCT03662542
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2completed
NCT02931799
Prevention of Readmissions at IBD Centres of ExcellenceNo drug interventionshealth_services_researchNot Availableunknown_status
NCT03606499
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory DiseasesNot AvailableNot Availablecompleted
NCT04121806
Diet Intervention Treatment for Active Ulcerative ColitisNo drug interventionstreatmentNot Availableunknown_status
NCT03535649
A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT02559713
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Diseasetreatment4completed
NCT01880918
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRingNo drug interventionsNot AvailableNot Availableunknown_status
NCT04613518
A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitistreatment2completed
NCT02550418
Budesonide 9 mg Capsules in Active UCtreatment2completed
NCT02676817
Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02986724
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)No drug interventionsNot AvailableNot Availablecompleted
NCT01990716
Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel DiseasesNo drug interventionsotherNot Availablecompleted
NCT04799496
A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic PouchitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03482635
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitistreatment2 / 3completed
NCT03710486
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT03090139
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging MarketsNo drug interventionsNot AvailableNot Availablecompleted
NCT06338930
Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance TherapyNo drug interventionsotherNot Availablenot_yet_recruiting
NCT03488030
A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablecompleted
NCT02646657
An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitistreatment4completed
NCT02445365
Remote Ischemic Conditioning in Patients With Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03464474
Digital Holographic Microscopy: Evaluation of Histological Disease Activity in Patients With Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT01900574
A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitistreatment1completed
NCT04885920
A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)No drug interventionsNot AvailableNot Availablecompleted
NCT03123120
A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapytreatment2completed
NCT00488631
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT06176560
Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.treatment3not_yet_recruiting
NCT01453491
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitistreatment1completed
NCT01284062
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patientstreatment2completed
NCT02764229
Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative ColitisNo drug interventionstreatment2terminated
NCT03531892
A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitistreatment3completed
NCT02229344
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in KoreaNo drug interventionsNot AvailableNot Availablecompleted
NCT02318667
Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).diagnostic4completed
NCT03915769
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT01100112
(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tabletstreatment3completed
NCT02493712
A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-Mtreatment2completed
NCT01534312
Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)treatmentNot Availablecompleted
NCT05456412
JAK Inhibition in Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02438410
Correlation of Infliximab Levels With Outcomes in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00928681
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative ColitisNo drug interventionstreatment1completed
NCT03172195
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-upNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT00468455
Post-Op Quality of Life After Colorectal SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05999708
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participantstreatment1withdrawn
NCT00001184
Immune Regulation in Ulcerative Colitis or Crohn s DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03950232
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT04424303
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative ColitisNot AvailableNot Availablerecruiting
NCT04624230
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitistreatment3recruiting
NCT05061446
Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitistreatment2completed
NCT05494606
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World PracticeNo drug interventionsNot AvailableNot Availablerecruiting
NCT05679622
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)No drug interventionstreatmentNot Availablerecruiting
NCT06228352
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06257875
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitistreatment2recruiting
NCT06269185
Comparison Between Infliximab and Adalimumab on Patients With Ulcerative ColitisNot AvailableNot Availablecompleted
NCT06459297
Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06550310
Nutrition and Clinical Outcomes in IBDNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06583395
Quest to Analyze One Thousand Humans MeditatingNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02118584
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studiestreatment3terminated
NCT04996797
A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)treatment2active_not_recruiting
NCT05626088
A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in BrazilNo drug interventionsNot AvailableNot Availablerecruiting
NCT05782907
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.treatment3recruiting
NCT05784246
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitistreatment3recruiting
NCT06026449
Gluten-free Diet in PSC and IBDNo drug interventionstreatmentNot Availablerecruiting
NCT06029972
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitistreatment2recruiting
NCT06052059
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)treatment3recruiting
NCT03519945
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)treatment3recruiting
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)treatment3recruiting
NCT04855799
GI Permeability Change in Response to Aquamin®No drug interventionstreatment2completed
NCT05213234
Chronotherapy of 5-Aminosalicylic Acid in Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitistreatment2recruiting
NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)treatment4recruiting
NCT06137183
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)treatment2recruiting
NCT06231264
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT06260267
A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisNo drug interventionstreatment1withdrawn
NCT06290934
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitistreatment2recruiting
NCT06598943
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitistreatment2recruiting
NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative ColitisNo drug interventionstreatment2not_yet_recruiting
NCT00606346
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel DiseaseNot AvailableNot Availableactive_not_recruiting
NCT02770040
Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitistreatment4completed
NCT02808780
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative ColitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03643211
Xeljanz Special Investigation for Long-term Use in UC PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03679546
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitistreatment4active_not_recruiting
NCT04338204
Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In SwedenNot AvailableNot Availablerecruiting
NCT05384080
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in PolandNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05428345
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South KoreaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05549323
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative ColitisNo drug interventionstreatment1recruiting
NCT06575660
Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel DiseaseNo drug interventionsotherNot Availablerecruiting
NCT06581042
Study to Assess Treatment Patterns and Outcomes With Upadcitinib in Adult Participants With Inflammatory Bowel Disease in BelgiumNo drug interventionsNot AvailableNot Availablerecruiting
NCT03196427
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)treatment2active_not_recruiting
NCT03863704
Transcutaneous VNS to Treat Pediatric IBDNo drug interventionstreatmentNot Availablecompleted
NCT04312113
Angiographic Delivery of AD-MSC for Ulcerative ColitisNo drug interventionstreatment1recruiting
NCT04738942
A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Diseasetreatment3recruiting
NCT04987307
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitistreatment2active_not_recruiting
NCT05069259
Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.No drug interventionsNot AvailableNot Availableterminated
NCT05479058
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remissiontreatment3terminated
NCT05496348
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05570006
Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT06624579
Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC StudyNo drug interventionsotherNot Availablenot_yet_recruiting
NCT06625450
TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIStreatment4not_yet_recruiting
NCT06627556
A Study of Single and Multiple Ascending Doses of H021 in Healthy ParticipantsNo drug interventionstreatment1recruiting
NCT06126835
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsNot AvailableNot Availableactive_not_recruiting
NCT06420375
Treatment of UC With Novel TherapeuticsNo drug interventionstreatment2not_yet_recruiting
NCT06420492
Study of Novel Therapeutics for Acute Remedy of ColitisNo drug interventionstreatment2not_yet_recruiting
NCT06626165
Association Between Effectiveness of Mirikizumab and UC Patients with High Neutrophilic Infiltration in Epithelium of the Colonic Mucosatreatment4recruiting
NCT04827368
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04861597
Digital Behavioral Interventions in Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04877990
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitistreatment2completed
NCT05082428
This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.No drug interventionsNot AvailableNot Availablecompleted
NCT05539625
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative ColitisNo drug interventionsother2suspended
NCT05672199
Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitistreatment2active_not_recruiting
NCT05739162
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT05785715
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT05817942
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)Not AvailableNot Availablerecruiting
NCT05835973
Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.No drug interventionsotherNot Availablenot_yet_recruiting
NCT06609447
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitistreatment4recruiting
NCT06080048
A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative ColitisNo drug interventionstreatment1active_not_recruiting
NCT06188637
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Studytreatment4withdrawn
NCT06221995
Energy Expenditure in Patients With Ulcerative Colitis Undergoing SurgeryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06254950
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitistreatment2recruiting
NCT06515210
Personalized Anti-Inflammatory Fibres in Ulcerative ColitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06579443
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Settingtreatment4not_yet_recruiting
NCT06587828
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients with Autoimmune DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06614387
Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximabtreatment3not_yet_recruiting
NCT06595719
Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT06615765
Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative ColitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04522843
Analysis of Intestinal Defensin Expression in Acute GVHDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02128503
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseNo drug interventionspreventionNot Availableterminated
NCT03282903
The PRognostic Effect of Environmental Factors in Crohn's and ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05507203
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1treatment3recruiting
NCT03615690
The Influence of a Fasting Mimicking Diet on Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT05327790
LFMT vs Placebo in New Biologic Start for Ulcerative Colitistreatment2recruiting
NCT02808390
Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UCtreatment2terminated
NCT01551290
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitistreatment3completed
NCT00656890
A Study of MDX-1100 in Subjects With Active Ulcerative Colitistreatment2completed
NCT05386290
A Multicentered Prospective Cohort Study of Chinese IBD PatientsNot AvailableNot Availableunknown_status
NCT06089590
Ibd CAncer and seRious Infections in France (I-CARE 2)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01882764
HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitistreatment3terminated
NCT01757964
Bacteriotherapy in Pediatric Inflammatory Bowel DiseaseNo drug interventionstreatment1completed
NCT02864264
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitisscreening1terminated
NCT04695964
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal AnastomosisNo drug interventionsdiagnosticNot Availableunknown_status
NCT06582264
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitistreatment1not_yet_recruiting
NCT00268164
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitistreatment2terminated
NCT05767021
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT03124121
Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levelstreatment4completed
NCT05953402
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their OffspringNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00618202
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting ConditionstreatmentNot Availablecompleted
NCT00787202
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.treatment2completed
NCT05239702
Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesNo drug interventionstreatment0recruiting
NCT01417702
Endoscopy for Assessment of Mucosal Healing in IBDNo drug interventionsNot AvailableNot Availablecompleted
NCT05121402
Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative ColitisNo drug interventionstreatment2withdrawn
NCT02227602
Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04617184
Registry and Biorepository for IBD in Central TexasNo drug interventionsNot AvailableNot Availablerecruiting
NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityNo drug interventionsNot AvailableNot Availablecompleted
NCT05598684
SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04767984
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitisprevention2recruiting
NCT04998084
Advanced Therapy Registry of IBD PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03781284
PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative ColitisNo drug interventionsdiagnosticNot Availablecompleted
NCT02520284
Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitistreatment2 / 3terminated
NCT00705484
European Safety Registry in Ulcerative Colitis (P04808)Not AvailableNot Availablecompleted
NCT05316584
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD TherapyNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT05615779
Personalized B-fructan Diet in Inflammatory Bowel Disease PatientsNo drug interventionsbasic_scienceNot Availablerecruiting
NCT06107179
Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic TomographyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02888379
Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitistreatment2completed
NCT01375179
Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patientstreatment2terminated
NCT06315179
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05702879
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy SuccessNot AvailableNot Availablerecruiting
NCT02476643
Integrative Gastroenterology - an Observational TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT06042387
Diverse Ancestry Study in IBDNo drug interventionsNot AvailableNot Availablerecruiting
NCT02209987
Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adultstreatment1completed
NCT02618187
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitistreatment1completed
NCT00963287
Trial of Chinese Prescription on Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT02579733
Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitistreatment4terminated
NCT00790933
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Diseaseother3completed
NCT00751933
Vaccines and Dietary Oats in the Treatment of Ulcerative Colitistreatment2terminated
NCT01586533
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitistreatment2unknown_status
NCT02791854
Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02488954
Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative ColitisNo drug interventionstreatmentNot Availableterminated
NCT03935451
Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Diseaseprevention0recruiting
NCT01458951
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT01538251
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitistreatment3terminated
NCT02383953
SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in TwinsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01798953
Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing CholangitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01104753
A Study of Pentasa in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01363453
User Surveillance in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03675477
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.treatment2completed
NCT00883077
Assessment of Colonic Permeability by Confocal Laser EndomicroscopyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04006977
Multistrain Probiotics Reduces UC Depression and Anxiety ScoresNo drug interventionstreatmentNot Availableunknown_status
NCT05998577
A Personalized Approach to Abdominal Pain in Irritable Bowel SyndromeNo drug interventionstreatmentNot Availablerecruiting
NCT03944447
Outcomes Mandate National Integration With Cannabis as Medicinetreatment2recruiting
NCT02413047
Evaluate if Response to Infliximab or Adalimumab May be Regained With an ImmunomodulatortreatmentNot Availableterminated
NCT00048347
Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitistreatment2completed
NCT05225545
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitistreatment3recruiting
NCT00259545
Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitistreatment2completed
NCT02200445
Low Dose IL-2 for Ulcerative Colitistreatment1completed
NCT02665845
Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).treatment3completed
NCT05733845
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel DiseaseNo drug interventionsotherNot Availablerecruiting
NCT05698745
Immunological Characteristics of Preclinical IBD(EARLY)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04990245
pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03648398
Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availableunknown_status
NCT01387698
Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02319798
Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel DiseaseNo drug interventionsotherNot Availablecompleted
NCT02039505
Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitistreatment3completed
NCT03869905
Aquamin® as an Adjuvant Intervention for Ulcerative Colitissupportive_care2active_not_recruiting
NCT01882205
Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative ColitisNo drug interventionsdiagnosticNot Availablerecruiting
NCT01405105
Exacerbating Factors in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03980405
Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative ColitisNo drug interventionstreatmentNot Availableterminated
NCT04071405
Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04458805
Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female VolunteersNo drug interventionstreatment1completed
NCT02742597
Patient-Centred Innovations for Persons With Multimorbidity - OntarioNo drug interventionsotherNot Availablecompleted
NCT02878083
Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)treatmentNot Availableterminated
NCT01654783
Observational Study in the Management of Ulcerative Colitis With Oral 5-ASANo drug interventionsNot AvailableNot Availablecompleted
NCT04995783
Predicting Medication Response for Autoimmune DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT04556383
A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)No drug interventionstreatment2terminated
NCT02846961
Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00815061
Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel PopulationNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06298461
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.treatment4not_yet_recruiting
NCT06392061
Effect of Probiotic Administration on Patients With Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT03942861
Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol.Not AvailableNot Availableunknown_status
NCT04474561
Reduced Sulfur Diet in Ulcerative Colitis PatientsNo drug interventionsotherNot Availablecompleted
NCT03824561
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]Not AvailableNot Availableactive_not_recruiting
NCT04887428
Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availableunknown_status
NCT01177228
Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitistreatment2completed
NCT00618228
Bioequivalency Study of Balsalazide Capsules Under Fasting ConditionstreatmentNot Availablecompleted
NCT03301311
Personalized Research on Diet in Ulcerative Colitis and Crohn's DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03038711
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteersscreening1completed
NCT00102193
Study for the Treatment of Ulcerative Colitis With AdacolumnNo drug interventionstreatment3completed
NCT03441893
Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitistreatment1 / 2active_not_recruiting
NCT04596293
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative ColitisNo drug interventionstreatment2completed
NCT00398593
Methods of Improvement Adherence With Therapy in Ulcerative Colitis.No drug interventionssupportive_care3unknown_status
NCT05807971
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy SubjectsNo drug interventionstreatment1completed
NCT05663671
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBDNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00643071
Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patientstreatment3completed
NCT00259571
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.prevention2 / 3withdrawn
NCT01433471
Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis OvaNo drug interventionsbasic_scienceNot Availablecompleted
NCT00510978
Probiotics in GastroIntestinal Disordersprevention2 / 3unknown_status
NCT00790478
Melatonin and Ulcerative Colitis: A Pilot Clinical Trialtreatment2terminated
NCT03549988
Pro-active Fecal Calprotectin Monitoring PROMOTE-UCNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06569888
Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of Reflecting the Inflammatory State in the Affected Colonic Tract of Ulcerative Colitis PatientsNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT03998488
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitistreatment2completed
NCT02322307
Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of LifeNo drug interventionssupportive_careNot Availablecompleted
NCT00780507
Fecal Biomarker Study for Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05486507
Health Benefits of Tart Cherry in Ulcerative ColitisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01467609
PillCam Colon Capsule Endoscopy for Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01771809
Long-Term Safety Of PF-00547659 In Ulcerative Colitistreatment2completed
NCT00274209
Chromoendoscopy for Ulcerative Colitis SurveillanceNo drug interventionsNot AvailableNot Availablecompleted
NCT00326209
Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remissiontreatment3completed
NCT01536509
Improving Medication Adherence in Pediatric Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00568256
Mind/Body Medicine and IBD Flare-UpNo drug interventionsprevention1completed
NCT04290156
The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD)No drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT01567956
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Studytreatment3terminated
NCT02370056
Evaluation of 3D Visualization for Total ColectomyNo drug interventionstreatmentNot Availablecompleted
NCT05610956
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitistreatment0not_yet_recruiting
NCT00708656
The Colitis Once Daily Asacol Studytreatment3completed
NCT01694485
Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitistreatment2completed
NCT02465385
Single-dose Linaclotide for Capsule Endoscopy Preparationtreatment4completed
NCT03843385
Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitisNo drug interventionstreatment3recruiting
NCT03283085
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)treatment3completed
NCT01810185
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Diseasetreatment2withdrawn
NCT02092285
Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)treatment4completed
NCT02306785
TP0502-Pharmaco-Scintigraphic-Study and Amendmentbasic_science1completed
NCT00572585
Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitistreatment2completed
NCT05321485
The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBDNo drug interventionssupportive_careNot Availableunknown_status
NCT00145015
FishGastro Study: Fish Consumption and Gastro-Intestinal HealthNo drug interventionsdiagnosticNot Availablecompleted
NCT01837615
Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative ProctitisNo drug interventionstreatment2completed
NCT01772615
Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissletreatment4completed
NCT06352515
T Lymphocyte Subsets in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01010815
Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04607837
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitistreatment2completed
NCT06516237
Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative ColitisNo drug interventionsotherNot Availablenot_yet_recruiting
NCT05181137
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitistreatment3recruiting
NCT03640637
The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05482932
Health-related Physical Fitness in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04775732
Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Diseasetreatment4completed
NCT03565432
Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT00679432
(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitistreatment3completed
NCT02862132
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel DiseasestreatmentNot Availablecompleted
NCT05974332
Oncostatin M in Ulcerative Colitis PatientsNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04032652
Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving AsacolNo drug interventionsother2terminated
NCT03558152
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)treatment2completed
NCT04013152
Clinical Database of Colorectal Robotic SurgeryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05987852
Hyperbaric Oxygen Therapy for Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT03773952
Safety and Efficacy of PBF-677 in Ulcerative Colitis Patientstreatment2completed
NCT01456052
A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitistreatment2completed
NCT01678300
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)No drug interventionsNot AvailableNot Availablecompleted
NCT04576000
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availableterminated
NCT00209300
Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remissionprevention3completed
NCT03698500
Specific microRNAs as Potential Biomarker for Inflammatory Bowel DiseaseNo drug interventionsdiagnosticNot Availableunknown_status
NCT02789800
Patient-Centred Innovations for Persons With Multimorbidity - QuebecNo drug interventionsotherNot Availablecompleted
NCT05098600
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicNo drug interventionsNot AvailableNot Availablecompleted
NCT04923100
Therapeutic Effect of New Biologics in Crohn's DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02683759
Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitistreatment3unknown_status
NCT01706159
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitistreatment2terminated
NCT04653259
Digital Nutrition Therapy for Patients With IBDNo drug interventionsotherNot Availableunknown_status
NCT04909359
Characterization of CD Responders to VedolizumabNo drug interventionsNot AvailableNot Availablecompleted
NCT03093259
ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitistreatment2completed
NCT00783575
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03724175
The Role of Secondary Bile Acids in Intestinal Inflammationtreatment2 / 3recruiting
NCT05230875
Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT02264275
Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and AdolescentsNo drug interventionssupportive_careNot Availableunknown_status
NCT02277470
Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01290042
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.treatment1completed
NCT05427942
Yuflyma® (Adalimumab), Patient Experience After SwitchingNot AvailableNot Availableunknown_status
NCT02227342
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitistreatment1 / 2completed
NCT01505842
Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel DiseaseNo drug interventionsdiagnosticNot Availableunknown_status
NCT03359642
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha TherapyNo drug interventionsotherNot Availablecompleted
NCT01764542
Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk FactorsNo drug interventionspreventionNot Availablecompleted
NCT05019742
Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitistreatment2recruiting
NCT06316999
Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal AnastomosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT04018599
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSbasic_science1completed
NCT06548399
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05633706
Evaluation of the SIMBA Capsule for Small Intestinal DysbiosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04621006
The Contact Activation System and Ulcerative ColitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04835506
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trialtreatment4enrolling_by_invitation
NCT01988506
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesNo drug interventionstreatment2completed
NCT03808506
Relationship Between Baseline Burden of Disease and TDM in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03358706
A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitisother1suspended
NCT01124149
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitistreatment4completed
NCT00446849
Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)treatment4completed
NCT02266849
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Studytreatment3terminated
NCT04276649
A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative ColitisNot AvailableNot Availablecompleted
NCT05117749
Saffron and Ulcerative ColitisNo drug interventionstreatment2not_yet_recruiting
NCT04029649
Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative ColitisNo drug interventionstreatment2 / 3unknown_status
NCT05788549
Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative ColitisNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01320436
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitistreatment3completed
NCT00385736
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitistreatment3completed
NCT02994836
GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )treatment4completed
NCT05704413
Digestive Biobank for Exploring Microbiota-host InteractionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00299013
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitistreatment3completed
NCT03268213
Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate ColitisNo drug interventionstreatment0completed
NCT06113913
Subcutaneous Infliximab After A Previous Intravenous Dose Optimizationtreatment4recruiting
NCT04820413
Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic PouchitisNo drug interventionstreatmentNot Availablecompleted
NCT04014413
Safety and Efficacy of Fecal Microbiota TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT03053713
The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT05578313
Inflammatory Bowel Diseases (IBD) Cannabis RegistryNot AvailableNot Availablerecruiting
NCT03941418
Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT06381518
Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT03824418
The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06421818
Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative ColitisNo drug interventionstreatment2recruiting
NCT04743518
Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT00254618
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.Not Available1terminated
NCT00783718
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitistreatment3completed
NCT03251118
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT01783119
Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative ColitisNo drug interventionstreatment0unknown_status
NCT03768219
Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative ColitisNo drug interventionstreatment1terminated
NCT05481619
Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitistreatment4unknown_status
NCT05118919
A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative ColitisNo drug interventionstreatment1 / 2recruiting
NCT00663819
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal AnastomosesNo drug interventionstreatmentNot Availableterminated
NCT06109441
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to BiologicsNo drug interventionstreatment2recruiting
NCT00152841
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisNot Available2terminated
NCT00064441
FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitistreatment3completed
NCT01296841
Telemedicine To Provide Inflammatory Bowel Disease Outpatient CareNo drug interventionshealth_services_research2completed
NCT02735941
Study on Cannabinoid Receptor Expression in Gastrointestinal DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT06453317
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitistreatment2not_yet_recruiting
NCT05479617
Personalised Prediction Of Disease Course In Ulcerative Colitis Using Multimodal Machine Learning - Part Of The Presager ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT05058417
Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitistreatment2recruiting
NCT02289417
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitistreatment2completed
NCT02308917
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)No drug interventionsNot AvailableNot Availablerecruiting
NCT06469424
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)No drug interventionsNot AvailableNot Availablerecruiting
NCT00727324
Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitistreatment2completed
NCT01520324
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing ColonoscopyNo drug interventionsdiagnostic2completed
NCT01676324
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablecompleted
NCT03934216
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitistreatment2completed
NCT06534216
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01517516
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.No drug interventionsNot AvailableNot Availablecompleted
NCT01647516
Efficacy and Safety Study of Ozanimod in Ulcerative Colitistreatment2completed
NCT00409396
A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis DiseaseNo drug interventionsdiagnosticNot Availablecompleted
NCT02100696
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) InhibitorsNo drug interventionstreatment3completed
NCT06013696
Bleach and Urine Color in UC Patients Using 5ASANo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01640496
Vitamin D Treatment in Ulcerative ColitistreatmentNot Availablewithdrawn
NCT05931458
AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative ColitistreatmentNot Availablenot_yet_recruiting
NCT01768858
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeNot AvailableNot Availablecompleted
NCT02201758
Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot AssessmentNo drug interventionstreatmentNot Availablewithdrawn
NCT02550158
A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT04034758
Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT00279435
Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Studytreatment2 / 3terminated
NCT01896635
Faecal Microbiota Transplantation in Ulcerative ColitisNo drug interventionstreatment2completed
NCT02155335
Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)treatment4completed
NCT05686135
90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease PatientsNo drug interventionsotherNot Availablerecruiting
NCT04079335
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBDNo drug interventionsNot AvailableNot Availableunknown_status
NCT02213835
Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT05177835
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitistreatment2active_not_recruiting
NCT04750135
Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitistreatment2unknown_status
NCT02093663
Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitistreatment3completed
NCT06249763
Effects of Gluten Free Diet in Ulcerative ColitisNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05112263
Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative ColitistreatmentNot Availablenot_yet_recruiting
NCT02084186
Moxibustion for Mild and Moderate Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03863886
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT02186886
Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumabdiagnostic4unknown_status
NCT01765439
The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel DiseaseNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT04000139
Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative ColitisNo drug interventionstreatment2completed
NCT01960439
Responsiveness of Endoscopic Evaluation in UCNo drug interventionsNot AvailableNot Availablecompleted
NCT00036439
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitistreatment3completed
NCT05372939
Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)treatment2completed
NCT01037322
Cannabidiol for Inflammatory Bowel Diseasetreatment1 / 2completed
NCT00604422
Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02914522
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT00449722
OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitistreatment3completed
NCT00279422
A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitistreatment2 / 3terminated
NCT03298022
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UCtreatment2terminated
NCT04131322
Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.treatment4terminated
NCT05530122
Prognosis in UC After First BiologicalNot AvailableNot Availablecompleted
NCT03669822
Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)No drug interventionsNot AvailableNot Availablerecruiting
NCT05886322
Remote Monitoring of IBDNo drug interventionsNot AvailableNot Availablerecruiting
NCT04939025
Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UCNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00366925
CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT04478825
Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative ColitisNo drug interventionstreatment1terminated
NCT01032525
Monroe County Inflammatory Bowel Disease (IBD) RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT04131530
Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial IntelligenceNo drug interventionsNot AvailableNot Availableunknown_status
NCT03504930
COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity.No drug interventionsNot AvailableNot Availableunknown_status
NCT00063830
ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.treatment2completed
NCT00810030
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORtreatment3completed
NCT00213330
Cerebral Resonance Magnetic Imaging During Rectal DistentionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03482648
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy VolunteersNo drug interventionstreatment1completed
NCT01532648
Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)treatment3completed
NCT00951548
Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative ColitisNo drug interventionssupportive_careNot Availablecompleted
NCT04659148
Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04898348
A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative ColitisNo drug interventionstreatment2withdrawn
NCT03949257
Dynamic Changes of Gut Microbiota in UC After FMTNo drug interventionsotherNot Availableunknown_status
NCT02065557
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitistreatment3completed
NCT01494857
Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitistreatment3unknown_status
NCT01026857
Propionyl-L-Carnitine in Ulcerative Colitistreatment2completed
NCT02745457
Body Composition in Children With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT06213857
Beneficial Effect of Silymarin in Ulcerative ColitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00622557
General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)No drug interventionsNot AvailableNot Availablecompleted
NCT02361957
The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis PatientsNo drug interventionsNot AvailableNot Availablesuspended
NCT00620126
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative ColitisNo drug interventionstreatment3completed
NCT02073526
Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel DiseaseNot AvailableNot Availablecompleted
NCT03872726
Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05791526
An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in JapanNo drug interventionsNot AvailableNot Availablerecruiting
NCT05719766
Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02182466
German Colon Capsule RegistryNo drug interventionsNot AvailableNot Availableterminated
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03538366
Fecal Microbiota Transplantation for Chronic PouchitisNo drug interventionstreatmentNot Availablecompleted
NCT04882566
Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05645666
The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative ColitisNo drug interventionssupportive_careNot Availablecompleted
NCT04165265
The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT01959165
MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsNo drug interventionstreatment2completed
NCT01336465
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2completed
NCT04388865
Patient Automated Text Hovering for IBDNo drug interventionshealth_services_researchNot Availablecompleted
NCT01731665
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.No drug interventionsNot AvailableNot Availablerecruiting
NCT03179865
Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06528665
Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsNot AvailableNot Availablerecruiting
NCT03757065
Cell Surface Marker Expression in Autoimmune DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01550965
A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Settingtreatment3completed
NCT05644665
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)treatment3recruiting
NCT05405465
Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in SwitzerlandNot AvailableNot Availablecompleted
NCT02958865
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitistreatment2completed
NCT03273465
Fecal Microbiota Transplantation in Ulcerative ColitisNo drug interventionstreatment2unknown_status
NCT01245465
Profermin® in Active Ulcerative ColitisNo drug interventionstreatment1 / 2completed
NCT04148274
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00548574
Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitistreatment3completed
NCT01458574
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitistreatment3completed
NCT05852574
CP101 for the Treatment of Ulcerative ColitisNo drug interventionstreatment1recruiting
NCT05404074
Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitistreatment1unknown_status
NCT03729674
Comparative Effectiveness and Safety of Biosimilar and Legacy DrugsNot AvailableNot Availableunknown_status
NCT00215020
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00167882
The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levelstreatment4completed
NCT03804931
Fecal Microbiota Transplantation for Ulcerative Colitistreatment2 / 3recruiting
NCT03947931
Russian Extremely Severe Ulcerative Colitis StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05458531
Monitoring of Inflammatory ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04096573
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative ColitisNo drug interventionstreatment2withdrawn
NCT00577473
Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)treatment3completed
NCT06073873
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in KoreaNot AvailableNot Availablerecruiting
NCT05336773
Ulcerative Colitis Mayo Score With Artificial IntelligenceNo drug interventionsNot AvailableNot Availableunknown_status
NCT01339273
Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic ResectionNo drug interventionstreatmentNot Availablecompleted
NCT03908073
Electrical Vagal Nerve Stimulation in Ulcerative ColitisNo drug interventionsotherNot Availableterminated
NCT05252273
Assessment of Patients With Acute Pouchitis Treated With AntibioticsNo drug interventionsNot AvailableNot Availablesuspended
NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Diseasetreatment1terminated
NCT00940576
Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT00516776
The Innate Immune System and Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01479660
Role of Healthy Bacteria in Ulcerative Colitistreatment4unknown_status
NCT02435160
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitistreatment2 / 3unknown_status
NCT03169894
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitistreatment1terminated
NCT05876494
Serum Lactate and Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01193894
Trial on Profermin and Fresubin in Ulcerative ColitisNo drug interventionstreatment2 / 3completed
NCT01149694
A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy VolunteersNo drug interventionstreatment1completed
NCT04543994
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)treatment1 / 2unknown_status
NCT03953794
Inflammatory Bowel Disease Tracker (IBD Tracker)No drug interventionsNot AvailableNot Availablewithdrawn
NCT03338894
A Trial of Yoga in Pediatric Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT04133194
Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitistreatment4recruiting
NCT05652491
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03798691
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumabbasic_science4active_not_recruiting
NCT04100291
Faecal Microbiota Transplantation in the Treatment of Chronic PouchitisNo drug interventionstreatmentNot Availableterminated
NCT02110862
Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT04469062
A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitistreatment3withdrawn
NCT04933162
UC Cohort - The Influence of Diet on Gut MicrobiotasNo drug interventionssupportive_careNot Availablecompleted
NCT01506362
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative ColitisNo drug interventionstreatment2completed
NCT05649462
Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02365480
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remissionprevention1completed
NCT03016780
Fecal Microbiota Transplantation for Ulcerative ColitisNo drug interventionstreatment1 / 2unknown_status
NCT03835780
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01216280
Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitistreatment2unknown_status
NCT03724929
Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative ColitisNo drug interventionspreventionNot Availableterminated
NCT00745329
The Effect of Infliximab on Sperm QualityNo drug interventionsNot AvailableNot Availableunknown_status
NCT03774329
Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablerecruiting
NCT05104229
SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgeryprevention3withdrawn
NCT01941589
Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitistreatment4completed
NCT05598489
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00619489
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Diseasetreatment2completed
NCT02065089
Development of 'Emma'--a Pediatric IBD QuizNo drug interventionshealth_services_researchNot Availablecompleted
NCT02135289
The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMIDNo drug interventionsNot AvailableNot Availablecompleted
NCT00498589
Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitistreatment2completed
NCT02734589
Fecal Transplantation Using a Diet for Donor and Recipient in Refractory ColitisNo drug interventionstreatmentNot Availableterminated
NCT05844592
First in Human, Single Ascending Dose StudyNo drug interventionstreatment1completed
NCT04189692
Evolution of Fatigue in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00151892
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitistreatment3completed
NCT00336492
A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitistreatment3completed
NCT05689892
Shared Decision Making in Paediatric Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03524092
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment3active_not_recruiting
NCT01966744
Self-Management Assistance for Recommended Treatment (SMART) PortalNo drug interventionsNot AvailableNot Availablecompleted
NCT05350644
Inflammatory Bowel Disease(IBD), Treatment ResponseNo drug interventionsNot AvailableNot Availableunknown_status
NCT01059344
Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitistreatment3completed
NCT04908644
MS-20 on Patients With Ulcerative Colitis(UC)No drug interventionssupportive_careNot Availablerecruiting
NCT01670240
Adalimumab in the Treatment of Chronic Pouchitistreatment3completed
NCT04804540
A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Diseasetreatment4completed
NCT02148640
The NOR-SWITCH Studytreatment4completed
NCT04883840
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitistreatment2 / 3recruiting
NCT02575040
Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Diseasetreatment3unknown_status
NCT04018040
Vegetarian Diet in IBDNo drug interventionstreatmentNot Availablecompleted
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)treatment3recruiting
NCT03452501
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsNot AvailableNot Availablecompleted
NCT01947101
Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Childrentreatment1completed
NCT05628701
Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.No drug interventionstreatmentNot Availablerecruiting
NCT03000101
Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel DiseaseNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT06281704
A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative ColitisNo drug interventionstreatment1completed
NCT03051204
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut MicrobiomeNo drug interventionsNot AvailableNot Availablecompleted
NCT00352404
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated DysplasiaNo drug interventionsdiagnostic3completed
NCT01349504
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02536404
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitistreatment2completed
NCT02179372
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT02066272
Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04434872
Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitistreatment2terminated
NCT02439372
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05394272
Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents.No drug interventionstreatmentNot Availablerecruiting
NCT02306772
TP0501 - Pharmaco-Scintigraphic-Studybasic_science1completed
NCT03747068
The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.No drug interventionsNot AvailableNot Availablecompleted
NCT02539368
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel DiseaseNot AvailableNot Availablecompleted
NCT03546868
Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel DiseaseNo drug interventionsdiagnostic2completed
NCT06424769
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease ManagementNo drug interventionssupportive_careNot Availablerecruiting
NCT03996369
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT03178669
The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitistreatment2completed
NCT03582969
Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis PatientsNo drug interventionstreatment2unknown_status
NCT05088369
Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201treatment1completed
NCT02136069
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitorstreatment3completed
NCT04277546
Open-label Extension Study of Brazikumab in Ulcerative Colitistreatment2terminated
NCT05535946
ABTECT - Maintenancetreatment3recruiting
NCT02423512
The Impact of Anti-TNF Exposure on Vedolizumab EffectivenessNo drug interventionsNot AvailableNot Availablecompleted
NCT02508012
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel DiseasesNo drug interventionsotherNot Availablecompleted
NCT02998112
Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubingtreatment4unknown_status
NCT01470612
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitistreatment3completed
NCT06071312
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential ApproachNo drug interventionstreatment1 / 2recruiting
NCT04505410
Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitistreatment3completed
NCT00713310
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitistreatment3completed
NCT00410410
A Study of Abatacept in Patients With Active Ulcerative Colitistreatment3completed
NCT01040910
Cannabis for Inflammatory Bowel Diseasetreatment1 / 2unknown_status
NCT02922881
Microbiota-targeted Diet for Pediatric UCNo drug interventionstreatmentNot Availablecompleted
NCT03290781
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitistreatment3completed
NCT05895981
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.No drug interventionstreatmentNot Availablerecruiting
NCT00303381
Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitistreatment2completed
NCT04985981
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) StudyNo drug interventionsNot AvailableNot Availablesuspended
NCT03269695
Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.No drug interventionstreatment2terminated
NCT04191395
Evolution and Treatments of Chronic Inflammatory Systemic DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00829595
Pneumococcal Vaccination in Patients With Inflammatory Bowel DiseasepreventionNot Availablecompleted
NCT00219414
Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)No drug interventionstreatment4completed
NCT01891214
Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02503514
Autoimmune Paradoxical Reactions in IBD Longitudinal CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT02620514
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)No drug interventionsotherNot Availablecompleted
NCT01839214
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitistreatment2completed
NCT03802214
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)TherapyNot AvailableNot Availableterminated
NCT03138655
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)treatment2completed
NCT00096655
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitistreatment3completed
NCT01620255
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisNo drug interventionstreatment2completed
NCT00343850
Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitisprevention3completed
NCT02144350
Hyperbaric Oxygen for Ulcerative ColitisNo drug interventionstreatment2 / 3terminated
NCT03765450
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative ColitisNot AvailableNot Availableactive_not_recruiting
NCT00521950
Cost-effectiveness of TPMT Pharmacogeneticssupportive_careNot Availablecompleted
NCT03943550
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)No drug interventionstreatment1terminated
NCT00403923
Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02277223
Curcumin in Pediatric Ulcerative ColitisNo drug interventionstreatment3withdrawn
NCT06398808
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral AminosalicylatesNo drug interventionstreatment2recruiting
NCT04183608
A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumabother4recruiting
NCT02913508
Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Diseasetreatment2withdrawn
NCT00145808
Wireless Capsule Endoscopy in Ulcerative ColitisNo drug interventionsNot Available3completed
NCT01020708
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitistreatment1completed
NCT01111708
Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU)No drug interventionstreatmentNot Availableunknown_status
NCT01545908
Fecal Biotherapy for the Induction of Remission in Active Ulcerative ColitisNo drug interventionstreatment2completed
NCT06094608
IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD SymptomsNo drug interventionstreatmentNot Availablerecruiting
NCT04564638
Long-term Outcome of Patients With Acute Ulcerative Colitis After First Course of Intravenous CorticosteroidsNot AvailableNot Availablecompleted
NCT02925338
National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeNo drug interventionsNot AvailableNot Availablecompleted
NCT00867438
Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on TherapyNo drug interventionstreatment2completed
NCT01650038
Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's HomeostasisNo drug interventionstreatment2completed
NCT00269438
New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative ColitisNo drug interventionstreatment3completed
NCT01659138
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitistreatment2terminated
NCT05561738
Nicotinamide Riboside in Ulcerative ColitisNo drug interventionssupportive_careNot Availablerecruiting
NCT02487238
Pediatric FEcal Microbiota Transplant for Ulcerative Colitistreatment1completed
NCT05896943
The Application of Transcriptomics in the Treatment of Ulcerative Colitis With UstekinumabNot AvailableNot Availableactive_not_recruiting
NCT00033943
Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative ColitisNo drug interventionstreatment2 / 3completed
NCT05051943
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT05246943
The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01692743
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)No drug interventionshealth_services_research3completed
NCT04205643
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)treatment3completed
NCT04924543
OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBDNo drug interventionsotherNot Availablecompleted
NCT02149043
Thermography in Surveillance of Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02818543
Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative ColitisNo drug interventionsNot Available1completed
NCT04408703
PRognOstiC valuE of rEd Density in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00114803
Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel DiseaseNot AvailableNot Availablecompleted
NCT03760003
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitistreatment2completed
NCT05205603
Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitistreatment4recruiting
NCT04060303
ENhanced Recovery in CHildren Undergoing SurgeryNo drug interventionshealth_services_research3recruiting
NCT00679003
Managing Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05466890
Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)No drug interventionstreatment2recruiting
NCT01468090
Disease Course in an IBD Cohort in the Era of Biological TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03366090
Immunological Profiles in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT01097590
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative ColitisNo drug interventionstreatment1completed
NCT04200690
Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory DiseasesNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT04188990
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related MalnutritionNo drug interventionstreatmentNot Availablecompleted
NCT04143490
Effects of Exercise in Patients With Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablesuspended
NCT05927064
Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05030064
Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With DepressionNo drug interventionstreatmentNot Availableunknown_status
NCT03952364
The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United StatesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03378921
Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitistreatment2completed
NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT00968721
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication UseNo drug interventionsNot AvailableNot Availableterminated
NCT05652621
Efficacy of Probiotics in Patients With IBDNo drug interventionssupportive_careNot Availablerecruiting
NCT01829321
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitistreatment2completed
NCT03616821
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2terminated
NCT06560021
Utility of Random Biopsies in Patients With Inflammatory Bowel DiseaseNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00073021
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitistreatment3completed
NCT05976802
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitistreatment4not_yet_recruiting
NCT02447302
Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitistreatment2completed
NCT06538402
Ileal Reservoir Length and Functional Outcome in Ileal Pouch-anal Anastomosis: An Assessor-blinded, Randomized Controlled TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03720002
HF2 Therapy in the Treatment of Active Ulcerative ColitisNo drug interventionstreatment1 / 2completed
NCT00659802
Phase II Study of HMPL-004 in Patients With Ulcerative Colitistreatment2completed
NCT03218202
Stricture Definition and Treatment (STRIDENT) Observational Study.No drug interventionsNot AvailableNot Availableterminated
NCT04257084
Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk GroupsNo drug interventionsdiagnosticNot Availableunknown_status
NCT04695184
Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal AnastomosisNo drug interventionsdiagnosticNot Availableunknown_status
NCT01482884
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitistreatment2completed
NCT04156984
Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitistreatment4completed
NCT06504784
The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03266484
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05684484
Role of Roflumilast in Ulcerative Colitistreatment4not_yet_recruiting
NCT02516384
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)treatment1completed
NCT05190484
bIosimilar of aDalimumab, an European evAluationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04223479
Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordantreatment2 / 3completed
NCT04969679
Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.treatment4completed
NCT05180279
The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT02506179
Impact of Adalimumab on Patient-reported Outcomes in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00209287
Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative ColitisNo drug interventionstreatment4terminated
NCT01002287
An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal SurgeryNo drug interventionspreventionNot Availableterminated
NCT01914887
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitistreatment1 / 2unknown_status
NCT02481687
The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)treatment3not_yet_recruiting
NCT05791487
Combination of Diet and Oral Budesonide for Ulcerative ColitistreatmentNot Availablerecruiting
NCT00628433
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitistreatment1 / 2completed
NCT02683733
Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitistreatment3unknown_status
NCT02054533
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02729233
Predicting Clinical Response to Golimumab With Mucosal Barrier DysfunctionNo drug interventionsotherNot Availablewithdrawn
NCT01090154
Study of Cimzia for the Treatment of Ulcerative Colitistreatment2completed
NCT01742754
Fecal Microbiota Transplantation for Ulcerative ColitisNo drug interventionsbasic_scienceNot Availableterminated
NCT00064454
FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitistreatment3completed
NCT04968951
Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)treatment0terminated
NCT01860651
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT02849951
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)treatment3terminated
NCT03455751
Precision Pain Management for Major Abdominal Surgery in Colorectal SurgeryNo drug interventionssupportive_careNot Availableterminated
NCT01496053
Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)No drug interventionstreatment2 / 3completed
NCT05743153
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative ColitisNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02330653
Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitistreatment1 / 2completed
NCT00769353
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical IllnessNo drug interventionsbasic_scienceNot Availablecompleted
NCT02025777
Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis DiseaseNo drug interventionsdiagnosticNot Availablecompleted
NCT00808977
A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitistreatment2completed
NCT00073047
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitistreatment2completed
NCT04626947
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).prevention4terminated
NCT05975047
A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC)No drug interventionstreatment1recruiting
NCT04057547
Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat SyndromeNo drug interventionstreatment0unknown_status
NCT02463045
Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjectstreatment1completed
NCT04033445
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2 / 3active_not_recruiting
NCT03772145
Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center StudyNo drug interventionsNot AvailableNot Availableterminated
NCT04709445
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal AnastomosesNo drug interventionsdiagnosticNot Availableunknown_status
NCT03257345
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03773445
Golimumab Trough Levels in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00652145
Dose Escalation and Remission (DEAR)prevention4completed
NCT02962245
Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitistreatment4withdrawn
NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancertreatment1recruiting
NCT04147598
Diet Study on Ulcerative ColitisNo drug interventionssupportive_careNot Availablecompleted
NCT02306798
TP0502-B-Pharmaco-Scintigraphic-Studybasic_science1completed
NCT02868398
Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With InfliximabNo drug interventionsNot AvailableNot Availablecompleted
NCT00430898
Basiliximab in Moderate to Severe Ulcerative Colitistreatment2completed
NCT06067698
Alpha Lipoic Acid in Ulcerative ColitistreatmentNot Availablenot_yet_recruiting
NCT01282905
Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT04401605
Fermented Food-Supplemented Diet in Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT03798405
Reactive vs. Proactive Pain Control in IBDNo drug interventionshealth_services_researchNot Availableterminated
NCT01393405
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitistreatment2completed
NCT00032305
Research Study in Patients With Severe Ulcerative Colitistreatment2 / 3completed
NCT02717897
Vitamin D and Disease Activity in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01491997
Mind-Body Medicine and Ulcerative ColitisNo drug interventionssupportive_careNot Availablecompleted
NCT05382897
Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBDNo drug interventionstreatment0recruiting
NCT06363383
A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy ParticipantsNo drug interventionstreatment1recruiting
NCT05431283
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated SpondyloarthropathyNot AvailableNot Availableunknown_status
NCT03589183
Gut Microbiome in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05809583
Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative ColitisNot AvailableNot Availablenot_yet_recruiting
NCT04882683
Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative ColitistreatmentNot Availableunknown_status
NCT05579483
Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome SignaturesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01790061
Standardized Fecal Microbiota Transplantation for Ulcerative ColitisNo drug interventionstreatment2 / 3recruiting
NCT00889161
Curcumin in Pediatric Inflammatory Bowel Diseasetreatment1completed
NCT06306261
Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02069561
Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal CancerNo drug interventionsbasic_scienceNot Availablecompleted
NCT05084261
An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)No drug interventionstreatment1completed
NCT01752361
Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transitNo drug interventionsNot AvailableNot Availableunknown_status
NCT01916161
The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04999228
Top Down Versus Step up in Pediatric Ulcerative Colitistreatment4recruiting
NCT03232528
The Promotion Plan of Moxibustion on Ulcerate ColitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03955328
Progression of Damage in Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT06353828
Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patientstreatment2active_not_recruiting
NCT01221428
Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative ColitisNo drug interventionstreatment1 / 2unknown_status
NCT00805428
Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control GroupNo drug interventionsNot AvailableNot Availableunknown_status
NCT01417728
Endomicroscopy in IBD PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03809728
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASENo drug interventionstreatmentNot Availablerecruiting
NCT00767728
Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitisprevention3completed
NCT04202211
FMT for Remission of Active Ulcerative Colitis in AdultsNo drug interventionstreatment2withdrawn
NCT00702611
Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative ColitisNo drug interventionstreatment4terminated
NCT01678911
Efficacy of Gralise® for Chronic Pelvic Paintreatment4terminated
NCT06206811
Phase 1 Study to Investigate OD-07656 in Healthy Adult ParticipantsNo drug interventionstreatment1recruiting
NCT05653011
Predictors of Prognosis in IBD PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06050811
Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)No drug interventionstreatmentNot Availablerecruiting
NCT03415711
PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitissupportive_careNot Availableterminated
NCT04004611
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)treatment2completed
NCT04159311
Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in RemissionNo drug interventionssupportive_careNot Availableterminated
NCT04706793
Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)treatment3completed
NCT03011593
Effect of UGIR in Adults With Compromised Gut Function and MalabsorptionNo drug interventionssupportive_careNot Availablecompleted
NCT05456893
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted TherapiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03872271
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL TrialNo drug interventionspreventionNot Availablerecruiting
NCT01065571
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease ActivityNo drug interventionsotherNot Availablecompleted
NCT00457171
GI-270384 Study In Patients With Mild To Moderate Ulcerative ColitisNo drug interventionstreatment1terminated
NCT04522271
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)No drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT04663971
Fertility and Pregnancy After Surgery IBD AuditNo drug interventionsNot AvailableNot Availablerecruiting
NCT03597971
HMPL004-6599 Phase I Dose-escalating Studytreatment1terminated
NCT05673278
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00222378
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00505778
A Comparison of Once a Day Dose Compared to 2 Doses/Daytreatment3completed
NCT01861288
Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02265588
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).No drug interventionstreatmentNot Availablecompleted
NCT00349388
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric PatientstreatmentNot Availableterminated
NCT03189888
Granulocyte-monocyte Apheresis in Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT00207688
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis PatientsNot AvailableNot Availablecompleted
NCT03536988
TAMIS-IPAA vs. Lap-IPAA for Ulcerative ColitiisNo drug interventionstreatmentNot Availableunknown_status
NCT03945188
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT04818788
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04882007
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitistreatment2unknown_status
NCT04191707
Metabolomic Markers of Fatigue in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01517607
Mesalazine (PENTASA®) in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00586807
Metabolic Response to Infliximab in Pediatric Ulcerative ColitisNo drug interventionsbasic_scienceNot Availableterminated
NCT02865707
Ulcerative Colitis Relapse Prevention by PrebioticsNo drug interventionspreventionNot Availablecompleted
NCT01171807
Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitistreatment2unknown_status
NCT03006809
Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitistreatment1completed
NCT05636709
National GMA Post-market Clinical Follow-up Study (GRACE)No drug interventionsNot AvailableNot Availablerecruiting
NCT03091309
Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel DiseaseNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01293656
Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)No drug interventionsNot AvailableNot Availablewithdrawn
NCT03478956
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Diseasetreatment1terminated
NCT04209556
A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitistreatment2withdrawn
NCT03074656
The Norwegian Drug Monitoring StudyNo drug interventionstreatmentNot Availablecompleted
NCT01759056
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitistreatment1completed
NCT00296556
Therapeutic Study of ONO-4819CD for Ulcerative Colitistreatment2terminated
NCT00805285
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitistreatment2terminated
NCT01004185
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitistreatment3terminated
NCT00979485
Microparticles in Pediatric Inflammatory DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT00350415
A Double Blind Study for the Treatment of Acute Ulcerative Colitistreatment3completed
NCT01417715
Endomicroscopy for Assessment of Mucosal HealingNo drug interventionsNot AvailableNot Availablecompleted
NCT00061737
Quality of Life in Pediatric Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT06331637
Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal AnastomosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02442037
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative ColitisNo drug interventionstreatment1 / 2unknown_status
NCT03973437
Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.No drug interventionshealth_services_researchNot Availableunknown_status
NCT01320332
A Study of a Single Dose of ASP3291 in Subjects With Ulcerative ColitisNo drug interventionsNot Available1completed
NCT03162432
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicadetreatment3active_not_recruiting
NCT03477032
FMT in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03209232
Infliximab Accelerated Induction in Moderate to Severe Pediatric UCtreatmentNot Availableterminated
NCT02606032
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitistreatment2completed
NCT04691232
Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative ColitisNo drug interventionstreatment1completed
NCT03561532
Fecal Transplantation in Ulcerative ColitisNo drug interventionstreatmentNot Availableunknown_status
NCT03521232
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditisother1 / 2terminated
NCT01095432
Partial Wave Spectroscopic Detection of Colon Cancer RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT02822352
RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding ColitisNo drug interventionsdiagnosticNot Availablecompleted
NCT00542152
Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitistreatment4completed
NCT00586352
Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel DiseaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT02502552
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT02425852
A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitistreatment4completed
NCT04456400
Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal AbnormalitiesNo drug interventionsNot AvailableNot Availablesuspended
NCT03832400
Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)No drug interventionstreatment1completed
NCT01813500
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04109300
Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel DiseaseNo drug interventionsotherNot Availableunknown_status
NCT03663400
Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool SamplesNo drug interventionsNot AvailableNot Availablecompleted
NCT03079700
Immune Modulation From Trichuris SuisNo drug interventionsNot AvailableNot Availablecompleted
NCT02750800
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)Not AvailableNot Availablecompleted
NCT02895100
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2terminated
NCT05463900
Microbial and Human Determinants of the Onset of IBD FlaresNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05542459
Multi-omics to Predict Responses to Biologics in IBDNo drug interventionsNot AvailableNot Availablerecruiting
NCT05892159
Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative ColitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02586259
Effectiveness of Cortiment® in Patients With Ulcerative ColitisNot AvailableNot Availablecompleted
NCT02163759
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitorstreatment3completed
NCT05662059
Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative ColitisNo drug interventionsotherNot Availablerecruiting
NCT02954159
Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UCtreatment3terminated
NCT02632175
Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitistreatment3active_not_recruiting
NCT00292175
NBI With Magnification for Dysplasia Detection in Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT05180175
The Nordic IBD Treatment Strategy TrialNo drug interventionstreatment4unknown_status
NCT04314375
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitistreatment4recruiting
NCT02910375
Golimumab Dried Blood Spot AnalysisNo drug interventionstreatment4unknown_status
NCT01697670
Photodynamic Therapy for Ulcerative Colitistreatment1unknown_status
NCT04881370
Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availableterminated
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesNo drug interventionstreatment2recruiting
NCT01095042
Cognition and Emotion in the SII and IBDNo drug interventionssupportive_careNot Availablecompleted
NCT00421642
Open-Label Adalimumab for Ulcerative Colitis Patientstreatment1completed
NCT05474742
The Nori Health AppNo drug interventionssupportive_careNot Availableterminated
NCT05992142
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASAtreatment4completed
NCT05651542
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel DiseaseNo drug interventionsotherNot Availablerecruiting
NCT00798642
Ulcerative Colitis Relapse Prevention Trial, HypnosisNo drug interventionspreventionNot Availablecompleted
NCT03849599
A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative ColitisNo drug interventionstreatment1completed
NCT04912999
Inflammatory Bowel Diseases Remission RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04637399
Circadian Misalignment in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00586599
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00578799
Effects of Probiotics in Patients With Ulcerative ColitisNo drug interventionstreatment1withdrawn
NCT05715099
Saffron as Anti Inflammatory In Patients With Inflammatory Bowel DiseaseNo drug interventionstreatment4not_yet_recruiting
NCT00853099
A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT02772406
Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT03711006
The Effect of Fecal Microbiota Transplantation in Ulcerative ColitisNo drug interventionstreatment1 / 2completed
NCT03262649
Manitoba Inflammatory Bowel Disease Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03581149
Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patientsdiagnostic4unknown_status
NCT02130349
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.No drug interventionsNot AvailableNot Availableunknown_status
NCT01861249
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)treatment2terminated
NCT03059849
Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBDtreatment4withdrawn
NCT05737836
Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial ExperiencesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03604536
Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableterminated
NCT02261636
Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis TreatmentNot AvailableNot Availablecompleted
NCT05722236
IBD Strong Peer2Peer for Self-Management of Psychological DistressNo drug interventionshealth_services_researchNot Availablerecruiting
NCT03104036
Faecal Bacteriotherapy for Ulcerative Colitistreatment2completed
NCT00895336
Lactobacillus GG in Pediatric Ulcerative Colitis (UC)No drug interventionstreatment2withdrawn
NCT04508413
A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and FunctionNo drug interventionsotherNot Availablecompleted
NCT05998213
Transfer of Feces in Ulcerative Colitis 2No drug interventionstreatment2recruiting
NCT03650413
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Diseasetreatment2terminated
NCT03142113
Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03885713
Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Diseasetreatment4recruiting
NCT00194818
Asacol Dosing Study for Active Ulcerative Colitisdiagnostic4completed
NCT03368118
Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitistreatment2unknown_status
NCT04223518
Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)No drug interventionstreatment0unknown_status
NCT00261118
Rituximab in Active Ulcerative Colitistreatment2 / 3completed
NCT02138318
High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC)No drug interventionstreatmentNot Availablecompleted
NCT02721719
The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03587519
Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch SurgeryNo drug interventionstreatmentNot Availableterminated
NCT03948919
Low Sulfur Fecal Transplant for Ulcerative Colitisbasic_science1completed
NCT00463619
Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative ColitisNot AvailableNot Availablecompleted
NCT04130919
Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitistreatment2terminated
NCT03136419
Microbiota and Immune microEnvironment in PouchitisNo drug interventionspreventionNot Availableunknown_status
NCT04225819
Adjunctive Treatment With Vitamin D3 in Patients With Active IBDNo drug interventionstreatmentNot Availablesuspended
NCT05488041
Anal Manometry Examination in Patients With Ulcerative ColitisNo drug interventionsdiagnosticNot Availableunknown_status
NCT03759041
A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitistreatment2terminated
NCT04862741
Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative ColitisNo drug interventionstreatment1completed
NCT06516341
Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal InflammationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06439641
Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel DiseaseNo drug interventionsdiagnosticNot Availablerecruiting
NCT04999241
Combined Application of EEN in the Induction of Remission in PUCtreatment4not_yet_recruiting
NCT03143517
Fecal Calprotectin Collection ProtocolNo drug interventionsNot AvailableNot Availablecompleted
NCT02542917
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01461317
Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitistreatment2completed
NCT02636517
Fecal Microbiome Transplanttreatment1recruiting
NCT02914717
The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05913817
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.Not AvailableNot Availablerecruiting
NCT02368717
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phasetreatment3completed
NCT03705117
Open-label V565 Target Engagement StudyNo drug interventionsbasic_science1completed
NCT03259334
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitistreatment3terminated
NCT05171634
Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)No drug interventionsscreeningNot Availablecompleted
NCT03324334
Prevalence of Graves Disease in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02684734
Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01771224
Effect of FAn-7 in UC ActivityNo drug interventionstreatment0unknown_status
NCT02058524
A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitistreatment1terminated
NCT00744016
Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitisprevention3completed
NCT01947816
Special Investigation in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06496516
Transperineal Ultrasound for Assessing and Predicting Response in Hospitalized Patients with a Flare of Ulcerative ColitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00537316
Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)treatment3terminated
NCT05994716
Telemonitoring for IBD Goodness Examination in RussiaNo drug interventionsotherNot Availableenrolling_by_invitation
NCT05507216
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2treatment3recruiting
NCT02057016
Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03986996
Antimicrobial Therapy for Ulcerative Colitis (UC)treatment2terminated
NCT06351696
The Effects of Bromelain Supplement in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT03860896
GB004 in Adult Subjects With Active Ulcerative ColitisNo drug interventionstreatment1completed
NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04023396
Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitistreatment2unknown_status
NCT06510296
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel DiseaseNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01061996
Basiliximab Maintenance in Ulcerative Colitistreatment2terminated
NCT00232258
Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety StudyNo drug interventionstreatment2completed
NCT00259558
Dose Finding Study for Retarded Phosphatidylcholine in Pancolitistreatment2completed
NCT04309058
Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphismtreatment0unknown_status
NCT04583358
Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)treatment2active_not_recruiting
NCT03327558
Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjectstreatment1completed
NCT01091558
Study of Effects of L-Arginine in Colitis and Colon CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06495658
Impact of Prebiotics in Ulcerative ColitisNo drug interventionsotherNot Availablerecruiting
NCT01078935
The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of InflammationNo drug interventionsprevention4unknown_status
NCT04757935
Yoga for Youth With IBD: a Pilot Feasibility StudyNo drug interventionstreatmentNot Availablecompleted
NCT01536535
Predicting Response to Standardized Pediatric Colitis Therapytreatment4completed
NCT02914535
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitistreatment3active_not_recruiting
NCT02499263
A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT06583863
Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve RemissiontreatmentNot Availablecompleted
NCT00553163
Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical TrialNo drug interventionstreatmentNot Availableterminated
NCT06143163
Clinical Outcome of Treatment of Ulcerative Colitis in AdultNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01465763
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitistreatment3completed
NCT01787786
Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody LevelsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03518086
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)treatment3completed
NCT01244386
Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03394586
Real-world Data Regarding Treatment of Ulcerative Colitis Patients With GolimumabNot AvailableNot Availableunknown_status
NCT04331639
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01716039
Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)treatment2terminated
NCT03884439
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)Not AvailableNot Availablecompleted
NCT01612039
Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative ColitisNo drug interventionstreatment2completed
NCT05606939
The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02622139
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)No drug interventionsdiagnosticNot Availablecompleted
NCT06120322
Machine Learning Approach to Study the Interactions Between Environment and Intestinal Tissue Homeostasis in IBDNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00360022
Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)No drug interventionsotherNot Availableterminated
NCT00467922
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomytreatment3completed
NCT01705522
Multimodal Approach in IBD PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05596422
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablecompleted
NCT00038922
Study Evaluating rhIL-11 in Left-Sided Ulcerative ColitisNo drug interventionstreatment1terminated
NCT01011322
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitistreatment2unknown_status
NCT00374725
Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.No drug interventionstreatmentNot Availablecompleted
NCT03018925
Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative ColitisNot AvailableNot Availablecompleted
NCT02142725
Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitistreatment3terminated
NCT04798625
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04963725
A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical PracticeNot AvailableNot Availablecompleted
NCT02749630
A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)treatment1completed
NCT05907330
Phase 2 Study of CU104 in Moderate-Severe Ulcerative ColitisNo drug interventionstreatment2not_yet_recruiting
NCT04898530
Diet Patterns in IBD in Central TexasNo drug interventionsNot AvailableNot Availablesuspended
NCT02693730
Phenotyping IBS: Perceptions and Modulations of Visceral SensationsNo drug interventionsNot AvailableNot Availablecompleted
NCT00793130
The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open LabelNo drug interventionstreatmentNot Availableunknown_status
NCT00490048
Assessment of Pulmonary Involvement inUlcerative Colitis by Induced SputumNo drug interventionsscreeningNot Availablecompleted
NCT03574948
5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scorestreatment2completed
NCT00961948
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00347048
Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patientstreatment3completed
NCT00791557
Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseasetreatmentNot Availablecompleted
NCT03404557
Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIECNo drug interventionsNot AvailableNot Availablecompleted
NCT05172557
IBD and Women's Health Wellness ProgramNo drug interventionsotherNot Availablecompleted
NCT04224857
SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101treatment1completed
NCT04722757
Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal AnastomosisNo drug interventionstreatmentNot Availablerecruiting
NCT00621257
Vitamin D Levels in Children With IBDNo drug interventionstreatmentNot Availableterminated
NCT01346826
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)treatment4completed
NCT01960426
Evaluation of Health Costs and Resource UtilizationNo drug interventionshealth_services_research4terminated
NCT02531126
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitistreatment3active_not_recruiting
NCT01882426
Care Path for the Management of Ulcerative ColitisNo drug interventionstreatment4terminated
NCT01846026
Ulcerative Colitis and Vitamin D Supplementationtreatment1 / 2withdrawn
NCT05176366
Study of ExoFlo for the Treatment of Medically Refractory Ulcerative ColitisNo drug interventionstreatment1active_not_recruiting
NCT04852666
Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablecompleted
NCT01289366
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablecompleted
NCT03182166
Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimizationtreatment2completed
NCT05626166
the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitistreatment3recruiting
NCT00065065
A Trial of Rosiglitazone for Ulcerative Colitistreatment2completed
NCT03794765
Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitistreatment2completed
NCT02589665
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitistreatment2completed
NCT02425865
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGETtreatment4completed
NCT03309865
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.treatment0withdrawn
NCT06525974
Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalaminetreatment0not_yet_recruiting
NCT02768974
Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative ColitisNo drug interventionstreatment2unknown_status
NCT06407674
Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00947674
A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)No drug interventionstreatment4terminated
NCT05743374
Micronutrient and Additive Modifications May Optimize Diet To HealthNo drug interventionsotherNot Availablerecruiting
NCT05916274
Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING)No drug interventionshealth_services_researchNot Availablecompleted
NCT00408174
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitistreatment3completed
NCT04151420
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported AssessmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01524120
Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD)No drug interventionsNot AvailableNot Availablewithdrawn
NCT06449820
Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03800420
Efficacy and Safety of BBT-401-1S in Ulcerative ColitisNo drug interventionstreatment2terminated
NCT05313620
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Eventstreatment4recruiting
NCT02469220
Diet Treatment of Patients With Ulcerative Colitis in RemissionNo drug interventionsbasic_scienceNot Availablecompleted
NCT06030882
Improving Patient Outcomes Through the Implementation of an IBD Biologic Care PathwayNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04897282
Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.No drug interventionsNot AvailableNot Availablerecruiting
NCT02020382
Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel DiseasesNo drug interventionsdiagnosticNot Availablecompleted
NCT04031482
TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate PartnersNo drug interventionsNot AvailableNot Availableunknown_status
NCT00295282
A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitistreatment1completed
NCT00061282
Clotrimazole Enemas for Pouchitis in Children and Adultstreatment1 / 2terminated
NCT05507931
Broccoli Sprouts for Mild Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT06116331
The Mind-Body IBD Study: Understanding the Mind-body Connection in IBDNo drug interventionsNot AvailableNot Availablerecruiting
NCT01418131
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitistreatment4completed
NCT00486031
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Studysupportive_care3completed
NCT04828031
Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Diseasetreatment1completed
NCT03689673
Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)No drug interventionsNot AvailableNot Availablecompleted
NCT03571373
PIBD-SETQuality: the Inception Cohort and Safety RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05587673
High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)treatment1recruiting
NCT04197973
Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic RemissionNo drug interventionsotherNot Availablerecruiting
NCT00307827
Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)treatment2terminated
NCT05761327
Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT03512327
Autoimmune Protocol Diet and Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT01831427
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitistreatment1completed
NCT04748627
Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st CenturyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01434576
Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative ColitisNo drug interventionstreatment1withdrawn
NCT04749576
Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT03237260
An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitistreatment4withdrawn
NCT02442960
Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative ColitisNo drug interventionstreatment1completed
NCT06335160
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With MesalaminetreatmentNot Availablenot_yet_recruiting
NCT00309660
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitistreatment1 / 2unknown_status
NCT02423460
Threonine Requirement in IBD Adults and Healthy Adult ControlsNo drug interventionsotherNot Availablecompleted
NCT01852760
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic UltrasoundNo drug interventionsNot AvailableNot Availablecompleted
NCT05666960
R-3750 in Patients With Mild to Moderate Ulcerative ColitisNo drug interventionstreatment1recruiting
NCT04303260
Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT04259060
Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remissiontreatment2withdrawn
NCT04577794
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative ColitisNo drug interventionstreatment2completed
NCT00573794
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitistreatment3completed
NCT02267694
Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative ColitisNo drug interventionstreatment1completed
NCT01517594
Tolerability of Pentasa Sachet in Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT04520594
OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND TrialNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT01387594
Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsNo drug interventionsbasic_science1completed
NCT02640391
Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01805791
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitistreatment3terminated
NCT02120391
Improving Knowledge of Medication in Ulcerative Colitis With an Iphone ApplicationNo drug interventionsotherNot Availablecompleted
NCT05653791
Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00816491
Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC)No drug interventionsdiagnosticNot Availablecompleted
NCT02931162
The Effects of Moxibustion on Ulcerative ColitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03341962
Phase 2 Dose-finding IMU-838 for Ulcerative Colitistreatment2terminated
NCT03839680
Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00694980
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative ColitisNo drug interventionstreatment1completed
NCT04006080
Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitistreatment4unknown_status
NCT00679380
(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitistreatment3completed
NCT02197780
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBDNo drug interventionsNot AvailableNot Availablecompleted
NCT03671980
IBD Self-management Website and Home Faecal Calprotectin MonitoringNo drug interventionsotherNot Availablecompleted
NCT02522780
Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)treatment3completed
NCT02093780
Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative ColitisNo drug interventionspreventionNot Availablecompleted
NCT03977480
Phase II Study of Hemay007 in Patients With Active Ulcerative ColitisNo drug interventionstreatment2terminated
NCT00408629
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitistreatment3completed
NCT02280629
Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)treatment3completed
NCT00803829
Synbiotic Treatment of Ulcerative Colitis PatientsNo drug interventionstreatmentNot Availablecompleted
NCT01745029
Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transitNo drug interventionsNot AvailableNot Availableunknown_status
NCT02144129
Effects of WB-EMS in Ulcerative Colitis PatientsNo drug interventionstreatmentNot Availablewithdrawn
NCT02171429
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitorstreatment3completed
NCT04241029
Boosting Biologics in UCNo drug interventionstreatmentNot Availablecompleted
NCT00737789
Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.treatment3completed
NCT03110289
Restoration of the Microbiome Through Superdonor SelectionNo drug interventionstreatmentNot Availableunknown_status
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Diseasetreatment3not_yet_recruiting
NCT01140789
GWA Study in Patients With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT01961492
Fecal Microbiota Transplantation in Patients With Ulcerative ColitisNo drug interventionstreatmentNot Availablewithdrawn
NCT02435992
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitistreatment3completed
NCT04114292
TUDCA as a Therapy for Ulcerative Colitis (UC)health_services_research1unknown_status
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT05579444
Systems Biology of Gastrointestinal and Related DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT01130844
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitisother1completed
NCT02161640
Vascular Dysfunction in Paediatric IBDNo drug interventionsNot AvailableNot Availablecompleted
NCT05500040
Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient RehabilitationNo drug interventionsNot AvailableNot Availablecompleted
NCT06023667
SMART-IBD App TrialNo drug interventionstreatmentNot Availablecompleted
NCT03847467
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapytreatment1 / 2recruiting
NCT02093767
Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT06069167
Bowel Urgency in Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00659867
Endomicroscopy in Ulcerative ColitisNo drug interventionsdiagnosticNot Availableterminated
NCT02522767
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)treatment3completed
NCT04650867
Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic TomographyNo drug interventionsNot AvailableNot Availablecompleted
NCT00355901
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative ColitisNot AvailableNot Availableterminated
NCT00837304
Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableterminated
NCT05214404
Effect and Mechanism of Dopamine on Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01164904
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitistreatment1terminated
NCT03281304
A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remissiontreatment4terminated
NCT03239704
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel DiseaseNo drug interventionshealth_services_researchNot Availableunknown_status
NCT06570772
Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyviotreatment3not_yet_recruiting
NCT04156672
Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In PortugalNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05447572
FIT Combining FC for Predicting MH and Histology Remission in UCNo drug interventionsNot AvailableNot Availablerecruiting
NCT03553472
Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes ZosterNo drug interventionsNot AvailableNot Availablecompleted
NCT01340872
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)treatment3completed
NCT02426372
Safety and Efficacy of QBECO in Moderate to Severe Ulcerative ColitisNo drug interventionstreatment2completed
NCT01929668
Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC PatientsscreeningNot Availablecompleted
NCT02131168
Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04985968
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitistreatment3terminated
NCT06571669
BOOM-IBD2 to Evaluate the Sacral Neuromodulation in IBD PatientsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04719169
MRI Anastomotic Integrity of Pelvic Intestinal AnastomosesNo drug interventionsdiagnosticNot Availablecompleted
NCT02610569
Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03483246
Impact of Fecal Microbiota Transplantation in Ulcerative Colitistreatment3recruiting
NCT05430412
CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative ColitisNo drug interventionstreatmentNot Availablerecruiting
NCT03836612
Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04857112
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative ColitisNo drug interventionstreatment2active_not_recruiting
NCT01408810
Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitistreatment4completed
NCT05743010
A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitistreatment1recruiting
NCT04231110
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitistreatment4recruiting
NCT00004810
Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitistreatment2completed
NCT02335281
Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Diseasetreatment2unknown_status
NCT05221281
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult CareNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT04329481
The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT03071081
Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjectstreatment1completed
NCT01287195
Oral OKT3 for the Treatment of Active Ulcerative Colitistreatment1 / 2completed
NCT01476995
Prognostic Indicators as Provided by the EPIC ClearViewNo drug interventionsNot AvailableNot Availablecompleted
NCT03952195
Complications and Outcomes of Pouch ExcisionNo drug interventionsNot AvailableNot Availablecompleted
NCT04499495
Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in KoreaNo drug interventionsNot AvailableNot Availablecompleted
NCT02274714
Dysmenorrhea in Women With Crohn's Disease and Ulcerative ColitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00063414
ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitistreatment2completed
NCT01991314
Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphatetreatment4completed
NCT03131414
The IMAGINE-SPOR CIHR Chronic Disease NetworkNo drug interventionsNot AvailableNot Availableunknown_status
NCT04924114
A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)No drug interventionstreatment1completed
NCT01562314
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)treatment2completed
NCT00917514
An Investigational Study to Test Usability of the Electronic Dosing Equipment MedicpenNo drug interventionsNot AvailableNot Availablecompleted
NCT04191655
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)No drug interventionsscreeningNot Availableenrolling_by_invitation
NCT02326155
To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)No drug interventionsNot AvailableNot Availableterminated
NCT05771155
Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®No drug interventionstreatment3recruiting
NCT02921555
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitisother4completed
NCT02852850
In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04398550
SCD vs. Mediterranean Diet Therapy in Ulcerative ColitisNo drug interventionstreatmentNot Availableunknown_status
NCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitistreatment1recruiting
NCT02084550
Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative ColitisNo drug interventionsbasic_scienceNot Availableunknown_status
NCT03151850
The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative ColitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01173250
Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?No drug interventionsNot AvailableNot Availablecompleted
NCT04687150
Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC)No drug interventionstreatmentNot Availablerecruiting
NCT00801723
(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.treatment3completed
NCT02291523
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative ColitisNo drug interventionstreatment1active_not_recruiting
NCT05186623
Prediction Model for Response to Biologics and Small Molecular Agent for UCNot AvailableNot Availablerecruiting
NCT06117423
Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Diseaseother1 / 2recruiting
NCT06311123
Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative ColitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02721823
Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative ColitisNo drug interventionstreatmentNot Availableunknown_status
NCT05780723
Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)treatmentNot Availablerecruiting
NCT00092508
CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remissiontreatment3completed
NCT03259308
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitistreatment3terminated
NCT02322008
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical PracticeNot AvailableNot Availablecompleted
NCT02337608
Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitistreatment2completed
NCT03397108
Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04178408
IBD Registry in a Sub-Saharan African PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05728008
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.Not AvailableNot Availablecompleted
NCT03594708
Immunonutrition in Ulcerative ColitisNo drug interventionssupportive_careNot Availableunknown_status
NCT01341808
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patientsprevention4completed
NCT03327038
Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel DiseaseNo drug interventionshealth_services_researchNot Availableunknown_status
NCT00720538
Thalidomide in Pediatric Inflammatory Bowel Diseases.treatment3completed
NCT06031038
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCUNo drug interventionsotherNot Availableactive_not_recruiting
NCT00781638
ADAPT Adacolumn Pediatric Trial in Ulcerative ColitisNo drug interventionstreatmentNot Availablecompleted
NCT06127043
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)treatment2recruiting
NCT03861143
Efficacy and Safety of Oral BT-11 in Ulcerative Colitistreatment2completed
NCT04360343
Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy SubjectsNo drug interventionsother1completed
NCT04011943
Fecal Microbiota Transplantation for Health Improvement (TFM3)No drug interventionstreatmentNot Availableunknown_status
NCT06116643
Pilot Study of a New Medical Food in the Management of Ulcerative ColitisNo drug interventionstreatment1not_yet_recruiting
NCT04718818
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitistreatment2recruiting
NCT02393248
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)treatment1 / 2terminated